Skip to search formSkip to main contentSkip to account menu

Carbidopa / Levodopa

Known as: Carbidopa and Levodopa, co careldopa, carbidopa-levodopa 
National Institutes of Health

Related topics

Related topics

17 relations

Broader (4)

Antiparkinson AgentsDopamine AgonistsDrug CombinationsImmunologic Adjuvants
CarbidopaCarbidopa 10 MG / Levodopa 100 MG Disintegrating Oral TabletCarbidopa 10 MG / Levodopa 100 MG Oral TabletCarbidopa 25 MG / Levodopa 100 MG Disintegrating Oral Tablet

Narrower (7)

GrifoparkinIPX066NacomNumient

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Novel dopamine releasing response of an anti-convulsant agent with possible anti-Parkinson’s activity
Summary.We used cerebral microdialysis to assess the ability of the anticonvulsant drug Zonisamide (ZNS) to release striatal… 
1999
1999
Effect of selegiline on dopamine concentration in the striatum of a primate
Review
1998
Review
1998
Initiating therapy for Parkinson's disease
Accurate diagnosis and individualized assessment of the risks and benefits of available antiparkinsonian medications should guide… 
1988
1988
Treatment of Parkinson's disease with pergolide: a double-blind study.
1988
1988
Pergolide: long-term use in Parkinson's disease.
1987
1987
Parkinson's disease complicated by anxiety.
Highly Cited
1985
Highly Cited
1985
Motor function in the normal aging population: treatment with levodopa.
In normal elderly humans there is progressive motor dysfunction and loss of nigrostriatal neurons and brain dopamine similar to… 
1983
1983
Long-term treatment of tardive dyskinesia with presynaptically acting dopamine-depleting agents.
Fourteen patients with TD, all but one also having tardive akathisia, were evaluated on presynaptically acting dopamine-depleting… 
1982
1982
Behavioral effects of carbidopa/levodopa in hyperactive boys.
Abstract Eight boys with attention deficit disorder with hyperactivity received a 3-week trial of carbidopa/levodopa (Sinemet… 
1980
1980
Increased ratio of carbidopa to levodopa in treatment of Parkinson's disease.
A randomized, double-blind clinical trial was designed to compare two ratios of carbidopa to levodopa (10 mg of carbidopa to 100… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)